Status:
COMPLETED
Study Evaluating Anxiety and Depression in Patients With Psoriatic Arthritis
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Psoriatic Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
This is an epidemiological non-interventional study assessing the prevalence of anxiety and/or depression disorders in patients suffering from Psoriatic Arthritis (PsA) in Spain.
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients both genders over 18 years old
- Patients with PsA diagnosis
- Exclusion criteria:
- Patients with PsA that suffer from other rheumatologic diseases or non-concomitant rheumatologic diseases that the investigator considers not to be appropriate for the study.
- Patients with any medical or physical condition (cognitive damage or difficulties for understanding) that create difficulties for reading and completing the questionnaires described in the protocol.
- Patients that in the study period are taking part in another clinical trial.
Exclusion
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
384 Patients enrolled
Trial Details
Trial ID
NCT00884468
Start Date
May 1 2008
End Date
December 1 2008
Last Update
May 27 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Reus, Tarragona, Spain, 43201